MYP_163269
Basic Information
HD5[L16R]
Anticancer Cytotoxic anticancer activity Cytotoxic
Antimicrobial
Antiviral
Antiviral Anti-Herpesvirus Anti-HSV
Antiviral Antiviral mechanism Viral entry inhibition
Antiviral Antiviral mechanism Viral entry inhibition Entry inhibitor
Toxicity / Safety Cytotoxicity Cytotoxic
Venom / Toxin General toxin Cytotoxic
Standard
32 amino acids
C144H245N53O45S6
Standard
Sequence
ATCYCRTGRCATRESRSGVCEISGRLYRLCCR
Physicochemical Analysis
3631.20 Da
9.22
4.74
4.46
0.1481
-0.37
0.81
-0.32
33.54
51.88
0.0625
2980.00
3355.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1635.16
-22.68
70.0
56.0
120.0
248.0
2.0
31.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0006057 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-31, 5-20, 10-30
Bio-Activity Profile
Antimicrobial Antiviral
Herpes simplex virus2(HSV-2):Potential for CaSki cell protection from HSV-2 infection(51.2% ± 7.2% cell protection at 100 μg/ml)
RECORD: Rec_0022630 VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
Defensin
9606;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Sequence-variant derivative
Bio-Activity Profile
Antiviral Entry inhibitor
Herpes simplex virus 2 (Virus entry); CaSki
18.451111 μM
Plaque assay
RECORD: Rec_0070825 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Defensin
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-31, 5-20, 10-30
Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.
Bio-Activity Profile
Antiviral Anti-HSV Entry inhibition
neutralization activity against HSV-2 during the preinfection stage
18.45 μM
IC50
Mammalian: 4.4 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0086612 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Defensin
32630
Structure & Mods
disulfide-constrained cyclic peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-31, 5-20, 10-30
Disulfide bonds between Cys3 and Cys31,Cys5 and Cys20,Cys10 and Cys30.
Bio-Activity Profile
Antiviral Anti-HSV Entry inhibition
Herpes simplex virus2 (HSV-2) | CaSki cell
100 μg/mL
% inhibition
Mammalian: 4.4 h; Yeast: >20 h; E. coli: >10 h
RECORD: Rec_0105741 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
None
None
3-31, 5-20, 10-30
Bio-Activity Profile
Antimicrobial Antiviral
CaSki cells up to 100μg/ ml
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2